More than 20% of U.S. high school seniors vaped THC in 2019: study
By Julie Steenhuysen CHICAGO (Reuters) – More than 20% of U.S. high school seniors reported...
Read More
Updated
Addictive nicotine in Juul nearly identical to a Marlboro: study
By Chris Kirkham (Reuters) – The nicotine formula used by controversial e-cigarette maker...
Read More
Clinic waiting room in Harlem becomes experiment in humanizing medicine
By Tamara Mathias and Ruhi Soni (Reuters Health) – Brightly-colored artwork by patients...
Read More
Sacklers withdrew over $10 billion in a decade from Purdue Pharma: New York Times
By Reuters Staff (Reuters) – The Sackler family – owners of Purdue Pharma –...
Read More
Biohaven Pharma says treatment for acute migraine succeeds in study
(Reuters) – Biohaven Pharmaceutical Holding Company Ltd said on Tuesday two doses of its...
Read More
U.S. sues CVS for fraudulently billing Medicare, Medicaid for invalid prescriptions
By Jonathan Stempel NEW YORK (Reuters) – CVS Health Corp <CVS.N> and its Omnicare unit...
Read MoreAdamas shares plunge 45% after drug to help MS patients walk disappoints
By Vishwadha Chander (Reuters) – Adamas Pharmaceuticals Inc said on Tuesday its drug to treat walking impairment in patients with multiple sclerosis did not show the clinical benefit the drugmaker was hoping for in a...
Read More
U.S. government extends deadline to sign up for Obamacare insurance plans
(Reuters) – The U.S. government said on Monday the deadline for signing-up for 2020...
Read More
Dengue fever finds breeding ground in war-weary Yemen
HAJJAH/HODEIDAH, Yemen (Reuters) – Ibrahim Ali al-Jadari’s four teenage daughters lie...
Read More
Bayer asks U.S. appeals court to reverse $25 million Roundup verdict
By Tina Bellon (Reuters) – Bayer AG on Monday said it has asked a U.S. federal appeals court...
Read More
BeiGene cancer drug fails in study against AbbVie: J&J’s Imbruvica
By Manojna Maddipatla and Tamara Mathias (Reuters) – BeiGene Ltd said on Monday a late-stage...
Read More
New autism guidelines focus on early diagnosis, treatment
By Julie Steenhuysen CHICAGO (Reuters Health) – The American Academy of Pediatrics (AAP) on...
Read More
Gilead’s NASH combination treatment fails mid-stage study
By Manas Mishra (Reuters) – Gilead Sciences Inc said on Monday all combinations of its three...
Read More
Axsome shares surge 75% after depression drug reduces symptoms in late-stage study
By Vishwadha Chander (Reuters) – Axsome Therapeutics Inc said on Monday its drug succeeded...
Read More
Novartis drops asthma drug fevipiprant after trial failures
ZURICH (Reuters) – Swiss drugmaker Novartis on Monday said it is jettisoning what it had...
Read More
Samoa extends measles state of emergency, NZ to fund Pacific vaccination campaign
By Will Ziebell MELBOURNE (Reuters) – The South Pacific island nation of Samoa on Saturday...
Read More
Sarepta shares surge after surprise approval of Duchenne Muscular Dystrophy drug
By Tamara Mathias and Michael Erman (Reuters) – Shares of Sarepta Therapeutics Inc...
Read MoreFDA panel votes unanimously in favor of Horizon’s thyroid eye disease drug
(Reuters) – Independent advisers to the U.S. Food and Drug Administration on Friday voted unanimously in favor of Horizon Therapeutics Plc’s experimental treatment for active thyroid eye disease, taking the drug...
Read MoreU.S. FDA approves Tandem’s predictive insulin pump software
By Julie Steenhuysen CHICAGO (Reuters) – The U.S. Food and Drug Administration on Friday granted approval for Tandem Diabetes Care’s software program that uses readings from a continuous glucose monitor to predict...
Read MoreCVS to increase genetic testing for some cancer patients
(This December 12 story corrects to Missouri from Montana in last paragraph) By Caroline Humer and Julie Steenhuysen NEW YORK (Reuters) – CVS Health Corp said on Thursday it will make it easier for patients with advanced...
Read More